JP2020515826A5 - - Google Patents

Download PDF

Info

Publication number
JP2020515826A5
JP2020515826A5 JP2019548777A JP2019548777A JP2020515826A5 JP 2020515826 A5 JP2020515826 A5 JP 2020515826A5 JP 2019548777 A JP2019548777 A JP 2019548777A JP 2019548777 A JP2019548777 A JP 2019548777A JP 2020515826 A5 JP2020515826 A5 JP 2020515826A5
Authority
JP
Japan
Prior art keywords
tumor marker
epcam
aif1
mmp9
hspa4
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019548777A
Other languages
English (en)
Japanese (ja)
Other versions
JP7249284B2 (ja
JP2020515826A (ja
Filing date
Publication date
Priority claimed from GBGB1619954.9A external-priority patent/GB201619954D0/en
Application filed filed Critical
Publication of JP2020515826A publication Critical patent/JP2020515826A/ja
Publication of JP2020515826A5 publication Critical patent/JP2020515826A5/ja
Application granted granted Critical
Publication of JP7249284B2 publication Critical patent/JP7249284B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019548777A 2016-11-25 2017-11-24 抗体アッセイ Active JP7249284B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1619954.9 2016-11-25
GBGB1619954.9A GB201619954D0 (en) 2016-11-25 2016-11-25 Antibody assay
PCT/GB2017/053541 WO2018096351A1 (en) 2016-11-25 2017-11-24 Antibody assay

Publications (3)

Publication Number Publication Date
JP2020515826A JP2020515826A (ja) 2020-05-28
JP2020515826A5 true JP2020515826A5 (https=) 2021-05-20
JP7249284B2 JP7249284B2 (ja) 2023-03-30

Family

ID=58073509

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019548777A Active JP7249284B2 (ja) 2016-11-25 2017-11-24 抗体アッセイ

Country Status (13)

Country Link
US (1) US20190376975A1 (https=)
EP (1) EP3545309B1 (https=)
JP (1) JP7249284B2 (https=)
KR (1) KR20190088510A (https=)
CN (2) CN108107218B (https=)
AU (1) AU2017365931A1 (https=)
BR (1) BR112019010636A2 (https=)
CA (1) CA3044492A1 (https=)
GB (1) GB201619954D0 (https=)
IL (1) IL266857A (https=)
MX (1) MX2019006098A (https=)
RU (1) RU2769987C2 (https=)
WO (1) WO2018096351A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109116023B (zh) * 2018-06-14 2021-06-04 郑州大学第一附属医院 一种肺癌标志物抗-mmp12自身抗体及其应用
CN109709335B (zh) * 2018-12-18 2020-10-27 中国医学科学院基础医学研究所 热休克蛋白hspa4在肿瘤转移预测、预后评估和治疗中的应用
CN109633165B (zh) * 2018-12-18 2021-03-09 中国医学科学院基础医学研究所 抗hspa4自身抗体作为乳腺癌诊断或预后评估标志物的应用
ES3039706T3 (en) * 2019-02-19 2025-10-24 Otsuka Denshi Kk Method for determining condition parameters for photodynamic therapy and photodynamic therapy apparatus
CN110579611B (zh) * 2019-09-18 2023-01-31 郑州大学 一种用于肺癌早期筛查和诊断的联合检测血清标志物、试剂盒及检测方法
JPWO2022118947A1 (https=) * 2020-12-04 2022-06-09
CN114994318A (zh) * 2022-06-16 2022-09-02 深圳上泰生物工程有限公司 一种用于检测akr1b10的试剂盒及其制备方法
CN116444680B (zh) * 2022-12-28 2024-05-03 杭州凯保罗生物科技有限公司 一种ralgds-krt8-aif1融合肿瘤抗原蛋白的制备方法及其应用
CN119639903B (zh) * 2025-01-17 2025-11-25 中山大学肿瘤防治中心(中山大学附属肿瘤医院、中山大学肿瘤研究所) 用于肝内胆管癌的生物标记物、药物及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7387881B2 (en) * 2001-09-19 2008-06-17 The Regents Of The University Of Michigan Detection and treatment of cancers of the liver
ITPD20030264A1 (it) * 2003-10-30 2005-04-30 Xeptagen Spa Metodo di diagnosi altamente specifico per neoplasie
TWI281473B (en) * 2003-12-19 2007-05-21 Ind Tech Res Inst Biomarkers for liver diseases and method for using same
CN1632589A (zh) * 2003-12-24 2005-06-29 财团法人工业技术研究院 肝脏疾病的生物标记分子及其检测方法
US20080254481A1 (en) * 2006-11-13 2008-10-16 Invitrogen Corporation Methods and kits for detecting prostate cancer biomarkers
CN102301237B (zh) * 2008-12-02 2014-05-14 财团法人工业技术研究院 用于肝纤维化诊断的生物标记
CN102356316B (zh) * 2009-03-05 2015-07-08 独立行政法人产业技术综合研究所 肝内胆管癌的检出、辨别方法
US20120309034A1 (en) * 2010-02-12 2012-12-06 Nitto Boseki Co., Ltd. METHOD FOR MEASURING IMMUNITY OF COMPLEX OF Ku86 AND AUTOANTIBODY THEREOF, KIT USED THEREFOR, AND METHOD FOR DETERMINING CANCER USING SAME
CN102175864A (zh) * 2011-01-19 2011-09-07 江苏永鼎股份有限公司 一组早期肝癌分子标志物及其应用
CN102507938B (zh) * 2011-10-08 2014-12-24 复旦大学附属中山医院 一种肝癌转移预测定量抗体芯片及试剂盒
US20150185226A1 (en) * 2012-07-23 2015-07-02 Inserm (Institut National De La Sante Et La Recherche Medicale) Method for Diagnosing Scleroderma
JP2014240771A (ja) * 2013-06-11 2014-12-25 日東紡績株式会社 Ku70/Ku86ヘテロダイマーに対する自己抗体の免疫測定方法、それに用いるキットおよびそれを用いた癌判定方法
GB201320061D0 (en) * 2013-11-13 2013-12-25 Electrophoretics Ltd Materials nad methods for diagnosis and prognosis of liver cancer
GB201411060D0 (en) * 2014-06-20 2014-08-06 Oncimmune Ltd Improved immunoassay method
TWI700493B (zh) * 2014-07-02 2020-08-01 香港商龍勝發展有限公司 用於非侵入性肝癌診斷之特異性生物標記組
CN104990905B (zh) * 2015-06-30 2017-12-29 曲凯 一种基于固相酶联免疫荧光斑点的肝癌转移诊断试剂盒

Similar Documents

Publication Publication Date Title
JP2020515826A5 (https=)
RU2019118625A (ru) Анализ антител
Kandil et al. Glypican‐3 immunocytochemistry in liver fine‐needle aspirates: a novel stain to assist in the differentiation of benign and malignant liver lesions
US12085569B2 (en) Plasma autoantibody biomarkers for basal like breast cancer
CN110753845B (zh) 用于实体瘤诊断的生物标志物绝对定量的方法和装置
US20140113310A9 (en) Cancer detection markers
WO2010065968A1 (en) Cancer detection markers
CN102027372A (zh) 使用抗磷脂酰肌醇蛋白聚糖3抗体的肝癌细胞的检测法
US20120295814A1 (en) CA-125 Immune Complexes as Biomarkers of Ovarian Cancer
JP2016507748A (ja) 卵巣癌の早期発見のための自己抗体サイン
Jin et al. A novel panel of biomarkers in distinction of small well-differentiated HCC from dysplastic nodules and outcome values
Jee et al. Midkine concentrations in fine‐needle aspiration of benign and malignant thyroid nodules
WO2024183369A1 (zh) Cited4和/或metrn在椎间盘退变程度的鉴别诊断中的应用
JP6876301B2 (ja) 肝細胞がん患者の再発リスク予測を補助する方法、装置、コンピュータプログラム製品及びキット
WO2018030511A1 (ja) エクソソームの膜に存在するタンパク質の検出方法
JP2023533815A5 (https=)
CN108254557A (zh) 用cd8阳性的t细胞上pd-1和tigit确定hbv相关原发性肝癌预后的系统
CN104053994B (zh) 测定
CN103608681A (zh) 用于检测肿瘤细胞的类固醇受体测定
Yussif et al. Assessment of neuroendocrine markers in different molecular subtypes of invasive breast carcinoma and its impact on prognosis
RU2741245C1 (ru) Способ ранней диагностики почечно-клеточной карциномы по наличию белка зрительного аррестина в сыворотке крови
BRPI0610267A2 (pt) métodos de detecção de um estado doentio ou de uma suscetibilidade à doença em um indivìduo mamìfero, e, uso do método
WO2025137302A1 (en) Liquid biopsy systems and methods for determination of cancer stages
TW201928351A (zh) 抗體測定